Share >  
Share
Share on Tumblr

Arun Sawhney

News »

   latest by relevance
Will end 2012 with higher sales, profits: Ranbaxy
Apr 25, 2012 at 22:07 | Source: CNBC-TV18
Ranbaxy managing director and chief executive Arun Sawhney told CNBC-TV18 that the pharmaceutical company would end fiscal 2012 with better sales and profits
Ranbaxy's roller coaster ride on settlement with US FDA
Dec 21, 2011 at 17:09 | Source: Moneycontrol.com
Ranbaxy shares ended 3% up on Wednesday in a roller coaster ride after the drug maker signed a consent decree with US FDA, and set aside USD 500 million to cover any liabilities arising from a US Justice Department probe.
Ranbaxy falls as US settlement provision to hurt earnings
Dec 21, 2011 at 11:56 | Source: Moneycontrol.com
Shares of Ranbaxy Laboratories fell over 3% on Wednesday after the drug maker said it has signed a consent decree with the US Food and Drug Administration [FDA] and also has separately set aside USD 500 million to cover any potential penalty from an investigation by the US Justice Department.
Ranbaxy jumps after final nod from USFDA to launch Lipitor
Dec 01, 2011 at 10:34 | Source: Moneycontrol.com
Ranbaxys shares jumped over 10% in morning trade on Thursday after it said it has launched its generic version of Lipitor in the US market having received final approval from US Food and Drugs Administration (FDA).
Received USD 5 m export incentive in Q3: Ranbaxy
Nov 11, 2010 at 10:58 | Source: CNBC-TV18
Drug maker Ranbaxy Laboratories has reported consolidated net profit at Rs 308 crore as against Rs 116.6 crore, a growth of 164.15% on year-on-year basis in the third quarter ended September.
Quit due to difference of opinion: Ranbaxy's outgoing CEO
Aug 12, 2010 at 18:04 | Source: CNBC-TV18
Ranbaxy Laboratories on Thursday said its chief executive was stepping down after just over a year in the top spot. In an interview with CNBC-TV18, Atul Sobti, the outgoing MD & CEO spoke on the development.

Videos »
Will end 2012 with higher sales, profits: Ranbaxy
Quit due to difference of opinion: Ranbaxy's outgoing CEO
Budget to focus on agri, weaker sections of society
more »

Photos »

  /  
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

167657 Followers

Ranbaxy Labs  

Source:Business Standard - US market. We will look at adding another b...

12.33 PM Dec 17th 2012

krishnastoc
comm

Platinum Member

166 Followers

Ranbaxy Labs  

. Synriam would cost Rs 130 for a complete course (one tablet each for...

10.12 PM May 28th 2012

Web Messenger

Platinum Member

167657 Followers

Ranbaxy Labs  

Source:Business Today - Arun Sawhney Drug major Ranbaxy...

5.54 PM May 8th 2012

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window